Monoclonal antibody specific for IDH1 R132H mutation

被引:335
|
作者
Capper, David [1 ]
Zentgraf, Hanswalter [2 ]
Balss, Joerg [3 ]
Hartmann, Christian [1 ,3 ]
von Deimling, Andreas [1 ,3 ]
机构
[1] Heidelberg Univ, Dept Neuropathol, Inst Pathol, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Monoclonal Antibody Unit, D-69120 Heidelberg, Germany
[3] German Canc Res Ctr, Clin Cooperat Unit Neuropathol G380, D-69120 Heidelberg, Germany
关键词
IDH1; Monoclonal antibody; Immunohistochemistry; Astrocytoma; Oligodendroglioma; Oligoastrocytoma; CODON; 132; MUTATION; GLIOMAS;
D O I
10.1007/s00401-009-0595-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IDH1 R132H mutations occur in approximately 70% of astrocytomas and oligodendroglial tumors. We developed a mouse monoclonal antibody targeting the IDH1 R132H mutation. Here, we show the high specificity and sensitivity of this antibody on Western blots and tissue sections from formalin fixed paraffin embedded tumor specimens. This antibody is highly useful for tumor classification, in detecting single infiltrating tumor cells and for the characterization of the cellular role of mutant IDH1 protein.
引用
收藏
页码:599 / 601
页数:3
相关论文
共 50 条
  • [41] IDH1 p.R132H ctDNA and D-2-hydroxyglutarate as CSF biomarkers in patients with IDH-mutant gliomas
    Fujita, Yoko
    Nunez-Rubiano, Luis
    Dono, Antonio
    Bellman, Allison
    Shah, Mauli
    Rodriguez, Juan C.
    Putluri, Vasanta
    Kamal, Abu Hena Mostafa
    Putluri, Nagireddy
    Riascos, Roy F.
    Zhu, Jay-Jiguang
    Esquenazi, Yoshua
    Ballester, Leomar Y.
    JOURNAL OF NEURO-ONCOLOGY, 2022, 159 (02) : 261 - 270
  • [42] IDH1 p.R132H ctDNA and D-2-hydroxyglutarate as CSF biomarkers in patients with IDH-mutant gliomas
    Yoko Fujita
    Luis Nunez-Rubiano
    Antonio Dono
    Allison Bellman
    Mauli Shah
    Juan C. Rodriguez
    Vasanta Putluri
    Abu Hena Mostafa Kamal
    Nagireddy Putluri
    Roy F. Riascos
    Jay-Jiguang Zhu
    Yoshua Esquenazi
    Leomar Y. Ballester
    Journal of Neuro-Oncology, 2022, 159 : 261 - 270
  • [43] Establishment of a Multi-Specific Monoclonal Antibody MsMab-1 Recognizing Both IDH1 and IDH2 Mutations
    Kaneko, Mika Kato
    Ogasawara, Satoshi
    Kato, Yukinari
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 230 (02) : 103 - 109
  • [44] Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations
    Tesileanu, C. Mircea S.
    Vallentgoed, Wies R.
    Sanson, Marc
    Taal, Walter
    Clement, Paul M.
    Wick, Wolfgang
    Brandes, Alba Ariela
    Baurain, Jean Francais
    Chinot, Olivier L.
    Wheeler, Helen
    Gill, Sanjeev
    Griffin, Matthew
    Rogers, Leland
    Ruda, Roberta
    Weller, Michael
    McBain, Catherine
    Reijneveld, Jaap
    Enting, Roelien H.
    Caparrotti, Francesca
    Lesimple, Thierry
    Clenton, Susan
    Gijtenbeek, Anja
    Lim, Elizabeth
    de Vos, Filip
    Mulholland, Paul J.
    Taphoorn, Martin J. B.
    de Heer, Iris
    Hoogstrate, Youri
    de Wit, Maurice
    Boggiani, Lorenzo
    Venneker, Sanne
    Oosting, Jan
    Bovee, Judith V. M. G.
    Erridge, Sara
    Vogelbaum, Michael A.
    Nowak, Anna K.
    Mason, Warren P.
    Kros, Johan M.
    Wesseling, Pieter
    Aldape, Ken
    Jenkins, Robert B.
    Dubbink, Hendrikus J.
    Baumert, Brigitta
    Golfinopoulos, Vassilis
    Gorlia, Thierry
    van den Bent, Martin
    French, Pim J.
    ACTA NEUROPATHOLOGICA, 2021, 141 (06) : 945 - 957
  • [45] Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations
    C. Mircea S. Tesileanu
    Wies R. Vallentgoed
    Marc Sanson
    Walter Taal
    Paul M. Clement
    Wolfgang Wick
    Alba Ariela Brandes
    Jean Francais Baurain
    Olivier L. Chinot
    Helen Wheeler
    Sanjeev Gill
    Matthew Griffin
    Leland Rogers
    Roberta Rudà
    Michael Weller
    Catherine McBain
    Jaap Reijneveld
    Roelien H. Enting
    Francesca Caparrotti
    Thierry Lesimple
    Susan Clenton
    Anja Gijtenbeek
    Elizabeth Lim
    Filip de Vos
    Paul J. Mulholland
    Martin J. B. Taphoorn
    Iris de Heer
    Youri Hoogstrate
    Maurice de Wit
    Lorenzo Boggiani
    Sanne Venneker
    Jan Oosting
    Judith V. M. G. Bovée
    Sara Erridge
    Michael A. Vogelbaum
    Anna K. Nowak
    Warren P. Mason
    Johan M. Kros
    Pieter Wesseling
    Ken Aldape
    Robert B. Jenkins
    Hendrikus J. Dubbink
    Brigitta Baumert
    Vassilis Golfinopoulos
    Thierry Gorlia
    Martin van den Bent
    Pim J. French
    Acta Neuropathologica, 2021, 141 : 945 - 957
  • [46] IDH1 R132C mutation is detected in clear cell hepatocellular carcinoma by pyrosequencing
    Lee, Jung Hee
    Shin, Dong Hoon
    Park, Won Young
    Shin, Nari
    Kim, Ahrong
    Lee, Hyun Jung
    Kim, Young Keum
    Choi, Kyung Un
    Kim, Jee Yeon
    Yang, Young Il
    Lee, Chang Hun
    Sol, Mee Young
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15
  • [47] Specific monoclonal antibodies against IDH1/2 mutations as diagnostic tools for gliomas
    Kato, Yukinari
    BRAIN TUMOR PATHOLOGY, 2015, 32 (01) : 3 - 11
  • [48] The R132H mutation in IDH1 promotes the recruitment of NK cells through CX3CL1/CX3CR1 chemotaxis and is correlated with a better prognosis in gliomas
    Ren, Feifei
    Zhao, Qitai
    Huang, Lan
    Zheng, Yujia
    Li, Lifeng
    He, Qianyi
    Zhang, Chaoqi
    Li, Feng
    Maimela, Nomathamsanqa R.
    Sun, Zhi
    Jia, Qingquan
    Ping, Yu
    Zhang, Zhen
    Chen, Xinfeng
    Yue, Ying
    Liu, Shasha
    Cao, Ling
    Zhang, Yi
    IMMUNOLOGY AND CELL BIOLOGY, 2019, 97 (05) : 457 - 469
  • [49] High-throughput immunohistochemical profiling of primary brain tumors and non-neoplastic systemic organs with a specific antibody against the mutant isocitrate dehydrogenase 1 R132H protein
    Ikota, Hayato
    Nobusawa, Sumihito
    Tanaka, Yuko
    Yokoo, Hideaki
    Nakazato, Yoichi
    BRAIN TUMOR PATHOLOGY, 2011, 28 (02) : 107 - 114
  • [50] Prevalence and Prognostic Value of IDH1 R132 Mutation in Newly Diagnosed AML Egyptian Patients with Normal Karyotype
    Salem, Dalia
    Abd El-Aziz, Sherin
    El-Menshawy, Nadia
    Abouzeid, Tarek
    Ebrahim, Mohamed
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2017, 33 (01) : 49 - 55